The Australian Colonic Advanced Mucosal Neoplasia & Endoscopic Resection

Status Active, not recruiting

Clinical Trial Summary

To enhance understanding of the risk factors for AMN, improve lesion assessment and prediction of submucosal invasive cancer, improve endoscopic resection efficacy, reduce complications of WF-EMR and improve the understanding of the progression of large lesions to cancer

Clinical Trial Description

The Australian Colonic Endoscopic Mucosal Resection study (ACE), is a multicentre prospective observational study which examined WF-EMR of colonic AMN (Ethics approval No. HREC JH/TG 2008/9/6.1(2858)). This project now has an extensive dataset from 8 leading colonic endoscopic resection centres in Australia on more than 1500 lesions resected over 4 years since June 2008. The ACE study has been successful in addressing several aspects of the resection of AMN, resulting in several high profile papers in internationally recognised journals. The collection of this data has produced robust information on the efficacy of the procedure4, recurrence rates7, bleeding complications8 and mortality when compared to surgery5. Single centre analysis of the ACE dataset at Westmead has also allowed insights into how to refine the procedure to improve outcomes. The target sign is now a recognised indication for the placement of clips to prevent perforation9, CO2 insufflation for WF-EMR has been shown to be superior to air insufflation10 and succinylated gelatin (Gelofusine®) has been shown to be superior to normal saline as a submucosal lifting agent11. There remain a number of unanswered questions regarding the endoscopic resection of large sessile lesions and expanding the ACE dataset in a new cohort of patients will allow these to be addressed. Enhancing the prediction of submucosal invasive cancer, advanced lesion classification, refinement of the assessment of deep injury, submucosal injectate constituents, the optimum electrosurgical resection methods, prevention and prophylaxis of bleeding, and subtype analyses of the different histological groups comprising AMN will be examined. ;

Study Design

Related Conditions & MeSH terms

Colonic Polyps

Clinical Trial Details

NCT number	NCT02000141
Study type	Observational
Source	Western Sydney Local Health District
Contact
Status	Active, not recruiting
Phase
Start date	January 2014
Completion date	January 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05615857` - Endocuff Enhanced Colonoscopy: Does it Improve Polyp Detection and Make Rectal Retroflexion Unnecessary	N/A
Not yet recruiting	`NCT02865382` - Detection of Colorectal Adenoma by Optical Enhancement Technology vs. High-Definition Colonoscopy	N/A
Completed	`NCT02529007` - Endo-cuff Assisted Vs. Standard Colonoscopy for Polyp Detection in Bowel Cancer Screening	N/A
Completed	`NCT02245854` - Efficacy and Safety of a New Polypectomy Snare for Cold-polypectomy for Small Colorectal Polyps	N/A
Completed	`NCT01712048` - Submucosal Injection EMR vs. Underwater EMR for Colorectal Polyps	N/A
Terminated	`NCT01297712` - Endoscopic Assessment of Polyp Histology	N/A
Active, not recruiting	`NCT01368289` - Australian Multicentre Colonic Endoscopic Mucosal Resection Study
Completed	`NCT02196649` - Clip Placement Following Endoscopic Mucosal Resection - Randomised Trial	N/A
Completed	`NCT00997802` - Japanese National Computed Tomographic (CT) Colonography Trial	N/A
Not yet recruiting	`NCT00996619` - Measuring the Spectrum of Tissues During Endoscopy	N/A
Completed	`NCT00468455` - Post-Op Quality of Life After Colorectal Surgery	N/A
Completed	`NCT00018551` - Chemoprevention With Folic Acid	Phase 2
Recruiting	`NCT02552017` - Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities	N/A
Completed	`NCT01979458` - Photometric Stereo Endoscopy (PSE) as a Tool for Imaging the Rectum and Colon	N/A
Unknown status	`NCT01101672` - Trial for Single Port Versus Conventional Laparoscopic Colectomy	Phase 2/Phase 3
Terminated	`NCT01458925` - Feasibility of Check-Cap's P1 Capsule System Screening	N/A
Recruiting	`NCT05737017` - The Efficacy and Safety of a Hybrid Hemostatic Device (ClearCoajet)	N/A
Recruiting	`NCT02760381` - Acetic Acid for Optical Characterization of Colonic Polyps	N/A
Withdrawn	`NCT04253990` - Efficacy and Safety of Precut-EMR for Resecting of Colonic Polyp	N/A
Completed	`NCT01901510` - Panchromoendoscopy Using Oral Indigo Carmine Mixed With Polyethylene Glycol Prep	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Australian Colonic Advanced Mucosal Neoplasia and Endoscopic Resection Study — ACER/AMN

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms